Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
Clinical Gastroenterology and Hepatology（2021）
Key words
Adverse Events of Special Interest,Inflammatory Bowel Disease,JAK Inhibitor,Tumor Necrosis Factor Antagonist
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined